Cipro Suspension/ Drops
Product Images NDC 66758-087

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cipro (NDC 66758-087). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Carton)

Packaging label for CIPRO HC Otic, a 10 mL suspension/drops containing ciprofloxacin hydrochloride 0.2% and hydrocortisone 1%, labeled for otic use. The label includes warnings that it is not for ophthalmic or oral use. Manufactured by Sandoz Inc, the label also shows instructions to shake well before use and various storage conditions.*

FDA Label Image

Ciprofloxacin Chemical Structure (Image 01)

Chemical structure of ciprofloxacin hydrochloride monohydrate, showing the molecular framework including fluorine, piperazine, and cyclopropyl groups, as well as carboxylic acid and ketone functionalities.*

FDA Label Image

Hydrocortisone Chemical Structure (Image 02)

Chemical structure diagram depicting the molecular structure of the active ingredient hydrocortisone, as part of the medication CIPRO HC which contains ciprofloxacin hydrochloride and hydrocortisone in a suspension/drops form for auricular (otic) use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.